摘要
目的:本研究旨在确定慢性过敏性肺炎(CHP)的生物标志物,促进CHP的精准基因治疗。 背景:慢性过敏性肺炎(CHP)是一种由吸入抗原的过敏反应引起的间质性肺病。在临床上,区分 CHP 和其他间质性肺疾病,尤其是特发性肺纤维化 (IPF) 的任务具有挑战性。目的:在本研究中,我们分析了 82 名 CHP 患者、103 名 IPF 患者和 103 名对照样本的公开基因表达谱,以确定 CHP 生物标志物。 方法:CHP 生物标志物采用高级特征选择方法进行选择:蒙特卡罗特征选择 (MCFS) 和增量特征选择 (IFS)。建立了支持向量机(SVM)分类器。然后,我们通过功能富集分析和差异共表达分析来分析这些 CHP 生物标志物。 结果:共有 674 个已识别的 CHP 生物标志物。 CHP中这些生物标志物的共表达网络包含更多的负调控,CHP的网络结构与IPF和对照的网络有很大不同。 结论:SVM 分类器可作为重要的临床工具来解决区分 CHP 和 IPF 的挑战性任务。差异共表达网络上的许多生物标志物基因在揭示 CHP 的潜在机制方面显示出巨大希望。
关键词: 慢性过敏性肺炎、生物标志物、精准基因治疗、特征选择、分类器、差异共表达网络。
图形摘要
Current Gene Therapy
Title:Identification of Chronic Hypersensitivity Pneumonitis Biomarkers with Machine Learning and Differential Co-expression Analysis
Volume: 21 Issue: 4
关键词: 慢性过敏性肺炎、生物标志物、精准基因治疗、特征选择、分类器、差异共表达网络。
摘要:
Aims: This study aims to identify the biomarkers for chronic hypersensitivity pneumonitis (CHP) and facilitate the precise gene therapy of CHP.
Background: Chronic hypersensitivity pneumonitis (CHP) is an interstitial lung disease caused by hypersensitive reactions to inhaled antigens. Clinically, the task of differentiating CHP and other interstitial lung diseases, especially idiopathic pulmonary fibrosis (IPF), was challenging.
Objective: In this study, we analyzed the publically available gene expression profile of 82 CHP patients, 103 IPF patients, and 103 control samples to identify the CHP biomarkers.
Methods: The CHP biomarkers were selected with advanced feature selection methods: Monte Carlo Feature Selection (MCFS) and Incremental Feature Selection (IFS). A Support Vector Machine (SVM) classifier was built. Then, we analyzed these CHP biomarkers through functional enrichment analysis and differential co-expression analysis.
Results: There were 674 identified CHP biomarkers. The co-expression network of these biomarkers in CHP included more negative regulations and the network structure of CHP was quite different from the network of IPF and control.
Conclusion: The SVM classifier may serve as an important clinical tool to address the challenging task of differentiating between CHP and IPF. Many of the biomarker genes on the differential coexpression network showed great promise in revealing the underlying mechanisms of CHP.
Export Options
About this article
Cite this article as:
Identification of Chronic Hypersensitivity Pneumonitis Biomarkers with Machine Learning and Differential Co-expression Analysis, Current Gene Therapy 2021; 21 (4) . https://dx.doi.org/10.2174/1566523220666201208093325
DOI https://dx.doi.org/10.2174/1566523220666201208093325 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Regulation of Blood Flow by Prostaglandins
Current Vascular Pharmacology Endotoxins: Relationships between Structure, Function, and Activity
Current Topics in Medicinal Chemistry Nanocrystal Technology in the Delivery of Poorly Soluble Drugs: An Overview
Current Drug Delivery Antioxidative Properties of Flavonoids
Current Organic Chemistry Development of Patient-Specific Hematopoietic Stem and Progenitor Cell Grafts from Pluripotent Stem Cells, In Vitro
Current Molecular Medicine Chemokines as Therapeutic Targets in Non-Small Cell Lung Cancer
Current Medicinal Chemistry - Anti-Cancer Agents Long-Term Multimodal Therapy (Verapamil Associated with Propolis, Blueberry, Vitamin E and Local Diclofenac) on Patients with Peyronie's Disease (Chronic Inflammation of the Tunica Albuginea). Results of a Controlled Study
Inflammation & Allergy - Drug Targets (Discontinued) Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Medical and Societal Impact
Current Immunology Reviews (Discontinued) New Treatment Strategies for Multiple Myeloma by Targeting BCL-2 and the Mevalonate Pathway
Current Pharmaceutical Design Boosting Interleukin-10 Production: Therapeutic Effects and Mechanisms
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Targeting Histone Deacetylases in Neuroblastoma
Current Pharmaceutical Design Flavonoids in the Treatment of Diabetes: Clinical Outcomes and Mechanism to Ameliorate Blood Glucose Levels
Current Diabetes Reviews Prostaglandin H Synthases and their Importance in Chemical Toxicity
Current Drug Metabolism Calcineurin Inhibition and Development: Insights from Research Models
Current Enzyme Inhibition Measurement of Serum Monoamine Oxidase in Lichen Planus Patients and Its Clinical Significance
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Soy Phytoestrogens and Breast Cancer Chemoprevention: Molecular Mechanisms
Current Nutrition & Food Science Topiramate in the New Generation of Drugs: Efficacy in the Treatment of Alcoholic Patients
Current Pharmaceutical Design Increased Serum Endotoxin and Elevated CD14 and IL-1β Expression in a Rat Model of Cerebrogenic Multiple Organ Dysfunction Syndrome
Medicinal Chemistry P-gp Transporter and its Role in Neurodegenerative Diseases
Current Topics in Medicinal Chemistry Inhibition of Interleukin-1 in the Treatment of Selected Cardiovascular Complications
Current Reviews in Clinical and Experimental Pharmacology